# L-carnitine

## L-Carnit inj 1gm/5mL

##### 臨採

| TAH Drug Code      | [ICARN](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ICARN)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Carnitine deficiency in patients with end-stage renal disease requiring hemodialysis (injection only), primary systemic carnitine deficiency and secondary carnitine deficiency.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | Carnitine deficiency causes Hemodialysis: 2g IV over 2 to 3 min after dialysis. [Micromedex 20210731] Carnitine deficiency, Secondary - Inborn error of metabolism ‧ initial, 50 mg/kg IV bolus (over 2 to 3 min) or infusion; repeat 50 mg/kg IV daily if clinically indicated; Maximum dose 300 mg/kg. ‧ severe metabolic crisis, initial, 50 mg/kg IV over 2 to 3 min bolus injection or infusion, repeat 50 mg/kg IV in divided dose over 24 hr (every 3 to 4 hr and not less than every 6 hr); repeat 50 mg/kg IV daily if clinically indicated; Maximum dose 300 mg/kg. Carnitine deficiency; Treatment and Prophylaxis - End-stage renal disease - Hemodialysis ‧ initial, 10 to 20 mg/kg (dry weight) over 2 to 3 min bolus injection after dialysis; subsequent dose titration determined by trough (predialysis) levocarnitine concentrations. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Contraindications  | Hypersensitivity to levocarnitine or any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | >10%: Cardiovascular: Hypertension (intravenous: 18% to 21%), chest pain (intravenous: 15%) Central nervous system: Headache (intravenous: 37%), dizziness (intravenous: 15% to 18%), paresthesia (intravenous: 12%) Endocrine & metabolic: Hypercalcemia (intravenous: 6% to 15%) Gastrointestinal: Diarrhea (intravenous: 35%), abdominal pain (intravenous: 21%), vomiting (intravenous: 21%), nausea (intravenous: 12%) Hematologic & oncologic: Anemia (intravenous: 5% to 12%) Infection: Infection (intravenous: 24%) Neuromuscular & skeletal: Weakness (intravenous: 9% to 12%) Respiratory: Cough (intravenous: 18%), rhinitis (intravenous: 11%) Miscellaneous: Accidental injury (intravenous: 12%), fever (intravenous: 6% to 12%)                                                                                                          |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| More Info          | [UpToDate](https://www.uptodate.com/contents/l-carnitine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |

